Calcineurin inhibitor monotherapy ab-initio after liver transplantation: 4 year follow up

被引：0
|
作者：
Dagher, L [1 ]
Rolando, N [1 ]
Patch, D [1 ]
Davidson, B [1 ]
Burroughs, A [1 ]
Rolles, K [1 ]
机构：
[1] Royal Free Hosp, Liver Transplantat Unit, London, England
来源：
JOURNAL OF HEPATOLOGY | 2001年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [41] Long term follow up of immunosuppressive monotherapy in liver transplantation: Tacrolimus and microemulsified cyclosporin
    Shusang, V.
    Raimondo, M.
    Marelli, L.
    Cholongitas, E.
    Senzolo, M.
    Davidson, B. R.
    Patch, D.
    Rolles, K.
    Burroughs, A. K.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 : S77 - S77
  • [42] Calcineurin-inhibitor-free immunosuppression with mycophenolate mofetil and sirolimus after cardiac transplantation is safe and improves renal function significantly: 1 year follow up.
    Groetzner, J
    Kaczmarek, I
    Mueller, M
    Adamidis, J
    Vogeser, M
    Ueberfuhr, P
    Daebritz, S
    Meiser, B
    Reichart, B
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 281 - 281
  • [43] Renal impairment after liver transplantation - a pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantation
    T Gerhardt
    B Terjung
    P Knipper
    H Palmedo
    RP Woitas
    J Kalff
    T Sauerbruch
    U Spengler
    [J]. European Journal of Medical Research, 14
  • [44] RENAL IMPAIRMENT AFTER LIVER TRANSPLANTATION - A PILOT TRIAL OF CALCINEURIN INHIBITOR-FREE VS. CALCINEURIN INHIBITOR SPARING IMMUNOSUPPRESSION IN PATIENTS WITH MILDLY IMPAIRED RENAL FUNCTION AFTER LIVER TRANSPLANTATION
    Gerhardt, T.
    Terjung, B.
    Knipper, P.
    Palmedo, H.
    Woitas, R. P.
    Kalff, J.
    Sauerbruch, T.
    Spengler, U.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 (05) : 210 - 215
  • [45] Conversion from Calcineurin Inhibitor-Based Immunosuppression to Mycophenolate Mofetil in Monotherapy Reduces Risk of De Novo Malignancies After Liver Transplantation
    Aguiar, Diego
    Martinez-Urbistondo, Diego
    D'Avola, Delia
    Inarrairaegui, Mercedes
    Pardo, Fernando
    Rotellar, Fernando
    Sangro, Bruno
    Quiroga, Jorge
    Ignacio Herrero, Jose
    [J]. ANNALS OF TRANSPLANTATION, 2017, 22 : 141 - 147
  • [46] Atypical calcineurin inhibitor-induced haemolytic uremic syndrome after liver transplantation
    Furmanczyk, Agnieszka
    Komuda-Leszek, Ewa
    Durlik, Magdalena
    [J]. ANNALS OF TRANSPLANTATION, 2009, 14 (04) : 47 - 51
  • [47] The choice of calcineurin inhibitor does not influence centrilobular necrosis after orthotopic liver transplantation
    Hassoun, Z
    Shah, V
    Petrovic, LM
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1519 - 1520
  • [48] IMPACT OF CALCINEURIN INHIBITOR THERAPY ON BRAIN-DERIVED CYTOKINES AFTER LIVER TRANSPLANTATION
    Dirks, M.
    Pflugrad, H.
    Tryc, A. B.
    Schrader, A. K.
    Ding, X.
    Lanfermann, H.
    Jaeckel, E.
    Barg-Hock, H.
    Klempnauer, J.
    Falk, C.
    Weissenborn, K.
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 37 - 37
  • [49] Successful Conversion to Rapamycin for Calcineurin Inhibitor-Related Neurotoxicity after Liver Transplantation
    Alvarez, Sergio C.
    Arcos, Mario
    Innocenti, Giulio R.
    Rossi, Ricardo A.
    Hurtado, Margarita
    [J]. LIVER TRANSPLANTATION, 2011, 17 (06) : S210 - S211
  • [50] Five year follow up of immune suppression with sirolimus for liver transplantation
    Gee, I
    Marshall, A
    Alexander, GJ
    [J]. GUT, 2004, 53 : A93 - A93
12345